Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-16FDA Approved: TICAGRELOR — Original Application (Solco Healthcare U.S., LLC)
The FDA approved a generic ticagrelor product under an original Abbreviated New Drug Application submitted by Solco Healthcare U.S., LLC.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150) [Phase 4]
A Phase 4 clinical trial update notes completion of a study evaluating adding a cholesterol-lowering drug to statin therapy in patients afte…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Nurses' Health Study (Cardiovascular Component)
The Nurses' Health Study cardiovascular component is currently active but not recruiting, with conditions including cardiovascular diseases …
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
This clinical trial update reports on outcomes of patients who survived ICU treatment for COVID-19 in England and Wales.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Long Term Predictors of Acute Myocardial Infarction in Patients With Coronary Revascularization
This clinical trial update reports the completion of a study investigating long-term predictors of acute myocardial infarction in patients w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Construction of a Cohort for Pan-Vascular Disease Among Employees of Taizhou People's Hospital
A clinical trial to build a cohort for pan-vascular disease among Taizhou People's Hospital staff, examining cardiovascular death, myocardia…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Acute Coronary Syndrome in Patients With COVID-19
A completed clinical trial from the Bulgarian Cardiac Institute evaluating acute coronary syndrome in patients with COVID-19.
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: Silent Myocardial Ischemia in Patients Undergoing Non-oncological Abdominal Surgeries
This clinical trial update notes a recruiting study at University Medical Centre Ljubljana examining silent myocardial ischemia and acute my…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: EMDR Treatment in PTSD Following Cardiac Events [NA]
A clinical trial is recruiting to evaluate Eye Movement Desensitization and Reprocessing (EMDR) for posttraumatic stress disorder after myoc…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial [NA]
This entry provides an update on the AGTP II trial evaluating adipose graft transposition procedure (AGTP) for myocardial scar in patients a…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: HIV-HEART Aging Study
The HIV-HEART Aging Study, sponsored by University Hospital Essen, is currently recruiting to investigate cardiovascular issues in people wi…
-
CLINICAL_TRIALS other · 2024-07-30Clinical Trial Update: Post-Myocardial Infarction Patients in Santa Catarina, Brazil - Catarina Heart Study
The Catarina Heart Study, a clinical trial in Santa Catarina, Brazil for post-myocardial infarction patients, is currently active but not re…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)
This clinical trial update describes the CADAMI-SPECTRAL study, which aims to characterize acute myocardial damage using spectral computed t…
-
FDA approval · 2024-07-22FDA Approved: VALSARTAN — Original Application (Zydus Lifesciences Limited)
FDA granted original approval for VALSARTAN (Valsartan) by Zydus Lifesciences Limited as a generic product under ANDA 218991.
-
EMA approval · 2024-07-19EMA Authorised: DuoPlavin (clopidogrel;acetylsalicylic acid) — Sanofi Winthrop Industrie
DuoPlavin, a fixed-dose combination of clopidogrel and acetylsalicylic acid, has been authorised by the EMA for treatment in acute coronary …
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Residual Inflammation and Plaque Progression Long-term Evaluation
This clinical trial update describes the long-term evaluation of residual inflammation and plaque progression in patients with atheroscleros…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health [NA]
This trial investigates time-restricted eating and its effects on anthropometric, metabolic, and cardiovascular health in individuals with a…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in ShangHai
A completed clinical trial conducted at Shanghai 10th People's Hospital investigated new-onset atrial fibrillation in patients with acute my…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF [Phase 3]
The APERITIF Phase 3 trial evaluating direct oral anticoagulants to prevent left ventricular thrombus after anterior acute myocardial infarc…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: SIRT1 Gene Polymorphism With Premature Myocardial Infarction in Young Egyptian Patients
This clinical trial studied the association between SIRT1 gene polymorphism and premature myocardial infarction in young Egyptian patients; …
-
FDA approval · 2024-07-08FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), a generic ACE inhibitor.
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
This clinical trial update describes an ongoing study evaluating survival and cardiovascular events in patients with acute myocardial infarc…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes [NA]
A clinical trial from Imperial College London is recruiting to study glucose monitoring after acute myocardial infarction in people with dia…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.
This clinical trial is evaluating the effectiveness of an early invasive treatment strategy in elderly patients with high-risk non-ST-segmen…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: A Genomic Approach for Clopidogrel in Caribbean Hispanics [EARLY_Phase 1]
A Phase 1 genomic study evaluating clopidogrel response in Caribbean Hispanics; current status is active but not recruiting.